Celldex Therapeutics Inc
SWB:TCE2
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Celldex Therapeutics Inc
SWB:TCE2
|
US |
|
LTC Properties Inc
NYSE:LTC
|
US |
|
A
|
Anthem Inc
F:A58
|
US |
|
C
|
CME Group Inc
LSE:0HR2
|
US |
|
D
|
Darden Restaurants Inc
SWB:DDN
|
US |
|
P
|
Panasonic Holdings Corp
F:MATA
|
JP |
|
P
|
Pultegroup Inc
DUS:PU7
|
US |
|
Proto Labs Inc
NYSE:PRLB
|
US |
|
S
|
Sino Land Co Ltd
OTC:SNLAF
|
HK |
|
W
|
Wheaton Precious Metals Corp
XBER:SII
|
CA |
|
I
|
Interpublic Group of Companies Inc
SWB:IPG
|
US |
|
R
|
Relx PLC
OTC:RLXXF
|
UK |
|
P
|
PNC Financial Services Group Inc
F:PNP
|
US |
|
M
|
Mueller Die lila Logistik SE
XMUN:MLL
|
DE |
|
A
|
Albemarle Corp
F:AMC
|
US |
|
R
|
Relx PLC
XHAM:RDEB
|
UK |
|
Wolters Kluwer NV
OTC:WTKWY
|
NL |
|
T
|
TransDigm Group Inc
XBER:T7D
|
US |
|
ITV PLC
LSE:ITV
|
UK |
|
F
|
Fujitsu Ltd
XMUN:FUJ1
|
JP |
Bankruptcy Probability
Celldex Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Celldex Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Celldex Therapeutics Inc
NASDAQ:CLDX
|
2.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
356.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
179.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
163B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
109.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
75.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
41.5B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
57.8B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Celldex Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Celldex Therapeutics Inc has no debt.
You can find a full breakdown on its Balance Sheet.
